4.8 Article

Catechol-metal coordination-mediated nanocomposite hydrogels for on-demand drug delivery and efficacious combination therapy

Journal

ACTA BIOMATERIALIA
Volume 129, Issue -, Pages 84-95

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.actbio.2021.05.006

Keywords

Nanocomposite hydrogel; Catechol; Doxorubicin; Combination therapy; Hyperthermia

Funding

  1. National Natural Science Foundation of China [51973234, 21775165]
  2. Natural Science Foundation of Jiangsu Province [BK20191326]
  3. Double First-Class University project [CPU 2018GY25]

Ask authors/readers for more resources

A magnetic nanocomposite hydrogel crosslinked by metal-ligand coordination was designed and synthesized to enhance mechanical strength and controllable drug release. The hydrogel showed longer retention time and effective anticancer potency both in vitro and in vivo, mediated by a combination therapy of chemotherapy and hyperthermia. Single-modality treatment with either chemotherapy or hyperthermia alone failed to achieve the same efficacy.
Hydrogels have drawn considerable attention in the field of drug delivery, yet their poor mechanical strength and uncontrollable drug release behavior have hindered further applications in clinical practice. Taking utility of metal-ligand coordination for structurally reinforcing the hydrogel network, we report design and synthesis of magnetic nanocomposite hydrogels (HA-DOPA center dot MNPs) that are crosslinked by DOPA-Fe(III) coordination existing between dopamine-conjugated hyaluronan (HA-DOPA) and iron oxide magnetic nanoparticles (MNPs). The MNPs in the nanocomposite hydrogel not only serve as structural crosslinkers, but also facilitate magnetic hyperthermia and on-demand release of doxorubicin (DOX) in HA-DOPA center dot MNPs/DOX hydrogels, for release rate of DOX accelerates when external alternating magnetic field (AMF) is ON, and it restores to a slow pace when AMF is OFF. Importantly, HA-DOPA center dot MNPs/DOX hydrogel shows a longer retention time than HA-DOPA/DOX gel or DOX solution in vivo . Further experiments confirm the efficacious anticancer potency of HA-DOPA center dot MNPs/DOX in vitro and in vivo , that is mediated by a combination therapy consisting of chemotherapy (DOX) and hyperthermia (MNPs). In contrast, single-modality treatment (DOX or hyperthermia only) fails to show an equivalent efficacy at the same dose.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available